| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Mar 17, 2025 | Mineralys Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +600,000 | 11.82% | ✗ | $8.1M |
| Nov 26, 2024 | Nov 27, 2024 | Neurogene Inc. | 10% Owner | Buy | 92.5 | +48,770 | 2.92% | ✗ | $1.3M |
| Feb 12, 2024 | Feb 14, 2024 | Mineralys Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +555,555 | 12.29% | ✗ | $7.5M |
| Oct 16, 2023 | Oct 18, 2023 | Scholar Rock Holding Corp | 10% Owner | Buy | 100.0 | +2,189,781 | 47.62% | ✗ | $15M |